YB-1 dependent oncolytic adenovirus efficiently inhibits tumor growth of glioma cancer stem like cells
Conclusion:
The results of this study supported YB-1 based virotherapy as an attractive therapeutic strategy for GBM treatment which will be exploited further in multimodal treatment concepts.
Source: Journal of Translational Medicine - Category: Research Authors: Klaus MantwillUlrike NaumannJanina SeznecVroni GirbingerHermann LagePawel SurowiakDagmar BeierMichel MittelbronnJürgen SchlegelPer Holm Source Type: research
More News: Adenoviruses | Brain | Brain Cancers | Brain Tumor | Cancer | Cancer & Oncology | Glioma | Neurology | Research | Stem Cell Therapy | Stem Cells | Study | Temodar | Virotherapy